Aslan gastric cancer phase II study shows +ve results

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2013

Singapore: Aslan Pharmaceuticals has revealed the results of its phase II clinical trial with Aslan001, a small-molecule...Read more

Sanofi, Regeneron cancer drug Zaltrap gets EU nod

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltr...Read more

Low R&D output, patent cliffs drives big pharma nuts

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 2 Comment | 05 Sep, 2012

Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined...Read more

Bayer, Compugen enter $500 mn cancer deal

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

Singapore: Israel-based Compugen and global pharmaceutical company Bayer are to jointly pursue a preclinical research pr...Read more

Taiho to start ph III trial in colorectal cancer

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combina...Read more

FDA nod for Genentech pre-surgical cancer drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 01 Oct, 2013

Singapore: Genentech, a member of the Roche Group, has recieved US FDA approval for Perjeta (pertuzumab) regimen for neo...Read more

FDA issues complete response letter for PREZISTA

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

Singapore: The US Food and Drug Administration (FDA) has issued a complete response letter to Janssen Therapeutics for ...Read more

Pharma majors join hands to find new cure for TB

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, rec...Read more

GSK to publish clinical study reports of drugs

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Feb, 2013

Singapore: Demonstrating its commitment to clinical trial transparency, multinational pharmaceutical company GlaxoSmithK...Read more

Ex-sanofi cancer head is PharmaEngine advisor

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 3 Comment | 05 Mar, 2013

Singapore: Taiwan's PharmaEngine appointed Dr Alain Herrera as senior advisor for clinical strategy, operations, corpora...Read more

Cold Spring Harbor Lab uses cancer drugs to treat Alzheimer's

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2012

Singapore: A team of American and Chinese neuroscientists at the Cold Spring Harbor Laboratory (CSHL) have carried out r...Read more

Chugai expands in Singapore with research institute

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2012

Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operati...Read more

Australia invests in autoimmune disease start up firm

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Helmedix, an early stage biopharmaceutical company developing novel therapies for autoimmune and inflammatory...Read more

François-Xavier Roge is Takeda's new CFO

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2013

Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief fi...Read more

Novartis, Regenerex further immune tolerance R&D

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2013

Singapore: Novartis entered into an exclusive global licensing and research collaboration agreement with Regenerex, a bi...Read more

Boehringer Ingelheim appoints board member

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

Singapore: The shareholders of Boehringer Ingelheim have appointed Dr Joachim Hasenmaier to Boehringer Ingelheim's board...Read more

China develops revolutionary TCM migraine medication

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2012

Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine ta...Read more

Novartis eye care firm gets EU nod for Jetrea

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 18 Mar, 2013

Singapore: Alcon, the global leader in eye care and a division of Novartis, has received European Commission's approval ...Read more